National Omics Data Encyclopedia

Notice: Private records are filtered that would not be displayed.

Sort:

PROJ zhenzhugang_mangrove_16s
Chengjian Jiang, Guangxi University,2021.03.27

Description

OEP001936
PROJ lignin
jialing li, Sun Yat-sen University,2023.08.15

Description

OEP004415
PROJ humanMK
Ma Yezi, ,2023.08.19

Description

OEP004425
PROJ precise medicine
Ruifang Cao, picb,2020.06.22

Description

OEP001025
PROJ Spatiotemporal Analysis of the Mammalian Megakaryocyte System Reveals Organ-specific Subpopulations and Distinct Developmental Dynamics
Ma Yezi, ihcam,2023.08.16

Description

OEP004418
PROJ The targets study of HDCA in ameliorating NAFLD induced by high-calories diet by multi-omics technology.
Jing Zhong, Shanghai University of Traditional Chinese Medicine,2022.12.21

Description

HDCA supplementation ameliorated diet-induced NAFLD in C57 wild type mice. In attempt to comprehensively understand the molecular mechanism occurring during the protective effect of HDCA, transcriptomic and proteomic profiles of mouse liver were first analyzed utilizing RNA-Sequencing and Tandem Mass Tag-based quantitative proteomic approach, respectively. Then, we screened for potential HDCA binding proteins by using biotin-labeled HDCA and human proteome microarray.

OEP003800
PROJ Soil microbial communities in paddy soils across China
Yahai Lu, Peking University,2023.03.13

Description

We carried out a comprehensive survey of soil microbial community composition in paddy soils across China

OEP004016
PROJ SNPcalling
Chengzhi Liu, ,2023.08.11

Description

OEP004405
PROJ Impacts of organic materials amendment on the soil antibiotic resistome in subtropical paddy fields
Zongming Li, Institute of Subtropical Agriculture, Chinese Academy of Sciences,2021.07.07

Description

OEP002404
PROJ KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression
Wenyun Guo, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital,2023.07.28

Description

Hepatocellular carcinoma (HCC) is one of major causes of death from cancer and has a very poor prognosis with few effective therapeutic options. Despite the approval of lenvatinib for the treatment of patients with advanced HCC, only a few of patients can benefit from this targeted therapy. Our study revealed that KDM6A is significantly upregulated in HCC and is associated with a poor prognosis. Hepatic Kdm6a loss also inhibited liver tumorigenesis in a mouse liver tumor model. Mechanistically, KDM6A loss downregulated the FGFR4 expression to suppress the PI3K-AKT-mTOR signaling pathway, leading to a glucose and lipid metabolism reprogramming in HCC.

OEP004319

Input Authorization code

Download Url: